My Account
We compare quotes from leading insurers
COMPLIANCE IS A RISK CONTROL — AND AN UNDERWRITING WEAPON
For medical device manufacturers, compliance isn’t “paperwork”. It’s how you prove to regulators, customers and insurers that you control risk. Strong MHRA / UKCA discipline and an ISO 13485-aligned quality system can reduce incidents, improve traceability, and strengthen your position if a complaint or adverse event becomes a claim.
This guide explains the compliance framework in plain English — and shows how to align your insurance programme with the risks that regulators care about: patient safety, post-market surveillance, traceability, change control and recall readiness.
MHRA & UKCA in Plain English
In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) is the regulator responsible for medical devices and market surveillance. UKCA is the product marking regime for placing medical devices on the Great Britain market (England, Scotland and Wales).
For manufacturers, the practical outcome is simple: you must be able to demonstrate that your devices are safe and perform as intended, that your technical documentation supports your claims, and that you can detect and act on real-world safety signals through post-market surveillance.
What MHRA Cares About Most
- Evidence that devices are safe and meet performance claims
- Robust complaint handling and adverse incident reporting
- Traceability and ability to quarantine/withdraw quickly
- Change control and supplier oversight
- Clear responsibilities and “manufacturer of record” clarity
- Effective CAPA and continuous improvement culture
What UKCA Readiness Looks Like
- Correct device classification and intended purpose definition
- Technical documentation organised, current and audit-ready
- Risk management aligned to real-world complaints
- Clinical evaluation / evidence supporting claims
- Labelling and IFU aligned to contraindications and warnings
- PMS plan and vigilance process that actually works
Why This Matters for Insurance
Underwriters price what they can’t see. A strong MHRA/UKCA compliance story reduces uncertainty and helps insurers offer broader cover, higher limits, and fewer restrictive endorsements. It also strengthens your defence if you ever face a clinical harm claim.
ISO 13485: The Quality System Insurers Expect to See
ISO 13485 is the globally recognised standard for quality management systems in the medical device industry. Even when not contractually required, it’s one of the strongest signals of control you can show an insurer.
Insurers don’t just want the certificate — they want confidence that the system is embedded: supplier controls, validation discipline, traceability, complaint trending and CAPA effectiveness.
Key ISO 13485 “Insurance-Visible” Controls
- Supplier qualification, audits and change notification controls
- Document control and audit trail integrity
- Process validation (sterilisation, packaging, bonding, coating)
- Incoming inspection and acceptance criteria
- Nonconformity handling and product release controls
- Complaint handling, trending and post-market surveillance
- CAPA discipline and effectiveness checks
- Training records and competence management
Most Common “Gaps” We See
- Change control exists but is not consistently followed
- Supplier changes not captured early enough
- Complaint data not trended into risk management
- CAPAs closed quickly but not proven effective
- Validation not updated after process changes
- Traceability exists but recall simulation not tested
- Documentation becomes “out of sync” with practice
UKCA vs CE / EU MDR: Why Export Changes Your Insurance
If you sell into the EU, the EU MDR framework (and CE marking) matters. If you sell UK-only, UKCA/MHRA is the core framework. But many manufacturers operate across both — and that changes territory, jurisdiction and underwriting expectations.
Export also changes claim dynamics. A device issue in one country can become a multi-jurisdiction dispute involving distributors, hospitals and insurers. That’s why territory/jurisdiction alignment in product liability is one of the most important items to get right.
Export Risks Insurers Focus On
- Where products are sold and where claims can be brought
- Distributor structures and contractual indemnities
- US/Canada exposure (often a separate underwriting decision)
- Language/translation controls for IFUs and labelling
- Vigilance reporting and field action capability across territories
- Evidence of traceability across the distribution chain
Insurance Actions to Take if You Export
- Confirm territory and jurisdiction are correct on PL/PI
- Ensure limits match contracts and patient exposure
- Consider product recall/remediation with overseas scope
- Check defence costs treatment and legal panel arrangements
- Review “vendor’s liability” / additional insured requirements
- Align transit/marine cargo cover with Incoterms
Compliance Events That Commonly Become Insurance Claims
Many losses start as “compliance events”: a complaint trend, a supplier deviation, a validation gap, a labelling error, or an adverse incident report. Whether it becomes a claim depends on severity, speed of response and how the situation is documented.
These are common pathways we see in medical device manufacturing:
Complaint Trend → Field Action → Recall Costs
Complaint trending identifies a signal. If the signal indicates a safety issue, you may need an FSCA or withdrawal. Recall/remediation insurance is designed for these costs (subject to wording and triggers).
- Complaint investigation costs (where included)
- Notifications and logistics
- Replacement, rework or relabelling
- Destruction and disposal
Adverse Incident → Patient Injury Claim → Product Liability
If a patient is harmed, the claim route is typically product liability (and sometimes PI/design). Early notification and documentation help preserve your position.
- Defence costs and legal strategy
- Medical expert review and causation analysis
- Settlement/compensation where legally liable
- Multi-party disputes involving distributors and hospitals
Supplier Change → Quality Drift → Defect / Recall Exposure
Uncontrolled supplier changes are a common root cause of device issues. Strong supplier agreements and change notification controls reduce the risk.
- Batch quarantine and investigation
- Re-testing and additional inspection costs
- Customer disputes and returns
- Potential recall/FSCA where safety impacted
Documentation Gap → Inspection Finding → Enforcement Risk
Weak documentation can turn a manageable issue into a serious enforcement event. While insurance won’t replace compliance, it can support with recall logistics, liability defence and (in some cases) management liability exposures depending on the allegation and policy scope.
- Enforcement action and market access restrictions
- Product withdrawal pressure
- Contractual fallout and indemnities
- Reputational impact and loss of confidence
Compliance + Insurance Checklist (Practical)
Use this checklist to ensure your compliance framework and insurance programme support each other. It also helps you prepare a clean underwriting submission.
Compliance Controls to Evidence
- ISO 13485 certificate (if held) + scope
- Device classification list and intended purpose statements
- Supplier audit plan and change notification clauses
- Validation summaries for critical processes
- Complaint handling SOP and trending approach
- CAPA log and effectiveness verification method
- Traceability/UDI approach and recall simulation evidence
- PMS plan and vigilance reporting responsibilities
Insurance Programme Checks
- Product liability territory/jurisdiction matches where you sell
- Limits match contract requirements and patient exposure
- PI/design liability included where you design/advise
- Recall/remediation cover arranged (and overseas scope checked)
- BI indemnity period reflects rebuild + revalidation timeline
- Supplier interruption considered for critical outsourced steps
- Cyber cover includes manufacturing interruption if needed
- Transit cover aligned to Incoterms and high-value shipments
FREQUENTLY ASKED QUESTIONS
Does having ISO 13485 reduce insurance premiums?
It can help. ISO 13485 is a strong signal of control and can reduce underwriting uncertainty, which may improve terms. However pricing also depends on device type/class, territories, limits, claims history and recall exposure.
Will insurance cover MHRA enforcement action or investigations?
Standard product liability usually focuses on third-party injury/property damage claims, not regulatory investigations. Some costs may be addressed via recall/remediation, management liability or specialist covers depending on wording. We help structure realistic protection.
What’s the biggest compliance-related insurance mistake manufacturers make?
Not disclosing exports, device class changes, or sterile/implantable exposure — and assuming product liability includes recall. Territory/jurisdiction and recall scope are frequent failure points.
Do UK-only manufacturers still need worldwide liability cover?
Not always, but you need cover that matches your actual distribution. If devices can be resold or used overseas, or if you supply distributors with international reach, you may need broader territory/jurisdiction.
What is an FSCA and why does it matter for insurance?
An FSCA (Field Safety Corrective Action) is an action taken to reduce risk of harm from a device in the field (e.g., correction, replacement, withdrawal). FSCAs often trigger significant logistics and communication costs, which are typically handled under recall/remediation cover (subject to wording).
How do compliance controls help defend product liability claims?
Strong records (validation, traceability, complaint investigations, CAPA effectiveness) help establish what happened, whether a defect exists, and what actions were taken. That evidence can materially improve defence outcomes and reduce settlement pressure.
Do we need product recall insurance if we’ve never had a recall?
Many recalls arise unexpectedly from supplier issues or complaint trends. Recall insurance is often purchased as a resilience tool — it can protect cashflow when you need to act fast, even if you’ve never had an event before.
What should we do first if we suspect a compliance breach?
Contain risk: quarantine affected batches, preserve records, start investigation, and follow your complaint/CAPA and reporting procedures. Notify your broker/insurer early if it may lead to a claim, recall or material loss.
Does exporting to the EU change compliance and insurance requirements?
Yes. EU MDR compliance and CE marking apply for EU sales, and insurance must match territories and where claims can be brought. Export also increases recall complexity and legal defence needs across jurisdictions.
How can Insure24 help with compliance-linked insurance placement?
We translate your quality and compliance controls into an insurer-friendly submission, structure cover around real risk pathways (PL, PI/design, recall, BI, cyber, transit), and ensure territory, limits and endorsements reflect how you actually operate.
ALIGN COMPLIANCE & INSURANCE
FOR MEDICAL DEVICE MANUFACTURING
If you’re UKCA/MHRA regulated, working to ISO 13485, exporting under CE/MDR, or simply want an insurance programme that respects how regulated manufacturing really works, Insure24 can help structure a joined-up solution.
WHAT WE HELP YOU PROTECT
- Patient injury and clinical harm allegations
- Recall and field action costs (where insured)
- Cleanroom and production asset resilience
- Regulatory-linked disruption pathways
- Export and multi-jurisdiction exposures
WHY INSURE24
- Device-aware broking and underwriting presentation
- Insurance structure aligned to compliance realities
- Support with territory/jurisdiction and contract requirements
- Fast quoting from specialist markets
- Ongoing advice as your devices and markets evolve